Sertindole

舍吲哚

Report date: 2022/04/18 17:18:24
NME

Base Information

Drug NameSertindole
Drug Alias Name施立碟sertindolesertindolum舍吲跺sertindol +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptor alpha-1 antagonistsSerotonin 2a (5-HT2a) receptor antagonistsDopamine D2 receptor antagonists
TargetsAdrenergic receptors alpha-1Serotonin 2a (5-HT2a) receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaCognition
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesH. Lundbeck A/S
Active IndicationsSchizophrenia
Inactive IndicationsCognition

Other Information

ATC CodeN05AE03
Related LinksWikipediaDrugBankKEGG